Blue Shield expects that 250 to 500 newborns will be eligible for the whole genome sequencing each year, which represents about 10 percent of their insured babies treated in neonatal intensive care units in California. Company executive vice president Terry Gilliland said he will encourage other Blue Cross and Blue Shield plans around the country to adopt a similar policy. “When you think about all the pain and suffering families go through with sick babies, this is going to be an enormous benefit,” he says.
# – # – # – # – #
I can think back to TWO babies in my life who could have used this. Maybe it could have prevented a one or both fatalities. And, maybe all the associated heartbreak.
Don’t know how much it costs, but like all technology the cost will come down.
Maybe it can be done on ALL babies as well as in the womb.
God’s gift to humanity, if it becomes so!
Dona Nobis Pacem
— 30 —